Healthcare

Global Rheumatoid Arthritis Drugs Market 2014-2018

  • TEC20241
  • 94 Pages
  • July 2014
  • Healthcare
About Rheumatoid Arthritis
RA is a chronic disease that leads to inflammation and pain in the human body's joints such as wrists, fingers, knees, feet, and ankles. In addition, it causes inflammation of the tissues that surround the joints and in other organs. The symptoms of RA begin slowly, usually just mild pain around the joints coupled with stiffness and fatigue, and in the later stages it causes inflammation of the joints. It can occur at any age, even in children, which is called juvenile arthritis. The disease is three times more common in women than in men. Genetic and environmental elements are known to contribute in the development of RA.
TechNavio's analysts forecast the Global Rheumatoid Arthritis Drugs market will grow at a CAGR of 4.09 percent over the period 2013-2018.
Covered in this Report
This report covers the present scenario and the growth prospects of the Global Rheumatoid Arthritis Drugs market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of various drugs used in the treatment of RA that are available in the market. The Global Rheumatoid Arthritis Drugs market can be divided into two segments: Symptomatic and DMARDs.
TechNavio's report, the Global Rheumatoid Arthritis Drugs Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Rheumatoid Arthritis Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions
Americas
EMEA
APAC
Key Vendors
AbbVie Inc.
Amgen Inc.
Bristol-Myers Squibb Co.
F. Hoffmann-La Roche Ltd.
Janssen Pharmaceuticals Inc.
Pfizer Inc.
Other Prominent Vendors

AB Science SA
Astellas Pharma Inc.
AstraZeneca plc
Biogen Idec Inc.
Boehringer Ingelheim GmbH
Celgene Corp.
Daiichi Sankyo Co. Ltd.
Eli Lilly & Co.
GE Healthcare Co.
Genmab A/S
GSK plc
Incyte Corp.
Merck & Co. Inc.
Mitsubishi Tanabe Pharma Corp.
Novartis AG
Novo Nordisk A/S
Rigel Pharmaceuticals Inc.
Sanofi
Takeda Pharmaceutical Co. Ltd.
UCB SA
Vertex Pharmaceuticals Inc.
Key Market Driver
Increasing Aging Population
For a full, detailed list, view our report.
Key Market Challenge
High Cost of RA Treatment
For a full, detailed list, view our report.
Key Market Trend
Increase in R&D Activities
For a full, detailed list, view our report.
Key Questions Answered in this Report
What will the market size be in 2018 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Please Select Format

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

Closed MRI Systems Market, by Field Strength (Low-to-Mid Field, High Field, Very High Field, Ultra High Field) and by Application (Brain, Spine, Cardiac, Breast, Abdominal) -Global Forecast to 2019

Magnetic Resonance Imaging (MRI) is a technique used in radiology to capture images of physiological processes in body. Closed MRI system is a tube-like tunnel with high field strength used ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Primary Progressive Multiple Sclerosis Market (Type of Diagnostic Test, Location of Treatment, and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2014 - 2021

Multiple sclerosis (MS) is an inflammatory disease of nervous system, which is also referred as disseminated sclerosis. Multiple sclerosis is progressed with disruption spinal cord and brain nerve cells, which ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Equine Healthcare Market (Therapeutic, Diagnostic, Supplement and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Global equestrian market consists of horse racing and betting, competitive riding and leisure. It supports various secondary markets of which equine healthcare is major. This market includes equine diagnostic ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Reprocessed Medical Device Industry - Market Insights, Analysis, and Forecast to 2021

Medical device reprocessing is scientific method of remanufacturing, disinfecting, testing, labeling as well as packaging of an undamaged, expired and used medical device to be put in service again at ...

July 2017  |   Price:$ 3499    | Pre Book Price:$ 3499

Read More >>

Global Haptic Technology Market (Components, Technology, Application, Geography)- Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2012 - 2020

Increasing demand of product differentiation to gain consumer loyalty is a major driving force to adopt advanced technologies. The adopted advanced technologies would make human interaction more appealing. The need ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Kidney Fibrosis Treatment Market (Type of therapeutic, Location of therapeutic, and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation, and Forecast, 2014 - 2021

Fibrosis is the body process in which excess fibrous connective tissue is formatted in the organ or tissue in repetitive way. Fibrosis may be resulted by specific injuries or diseases. Kidney fibrosis is the common pathway for the chronic kidney disease (CKD) or end-stage kidney diseases (ESRD).

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

2017 © Copyright Big Market Research

View Pricing >>